AlphaGrep UK’s GE HealthCare GEHC Stock Holding History

AlphaGrep UK’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4,798	Closed	-$307K	–	837
2026 Q2	$307K	Buy	4,798 +617	+15%	+$40.6K	0.09%	455
2026 Q1	$298K	Buy	+4,181	New	+$330K	0.09%	511

Other funds holding GEHC

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $31.5B AUM 27.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

AlphaGrep UK's GEHC Position: Q3 2026 in Review

AlphaGrep UK sold out of GE HealthCare (GEHC) in Q3 2026, closing a stake of 4,798 shares — an estimated $307K sold.

AlphaGrep UK first reported a position in GEHC in Q1 2026 and held it in 2 quarters. The position peaked at $307K in Q2 2026. 1,046 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

AlphaGrep UK reported no remaining GE HealthCare position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 4,798 GE HealthCare shares in Q3 2026, an estimated $307K.
AlphaGrep UK first reported a position in GE HealthCare in Q1 2026 and held it in 2 quarters.
AlphaGrep UK's GE HealthCare position peaked at $307K in Q2 2026.
1,046 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.